Atlanta Sheraton Hotel affected by Legionnaires’

Georgia News

LEGIONNAIRES OUTBREAK

55 ‘probable’ Legionnaires’ cases tied to Atlanta hotel

ATLANTA (AP) – The Georgia Department of Public Health says it’s probable there are 55 more cases in the Legionnaires’ disease outbreak linked to the Sheraton Atlanta Hotel.

News outlets report the agency hadn’t confirmed the cases in the lab Monday but the people involved have illnesses consistent with Legionnaires’ disease, such as pneumonia. There are 11 confirmed cases but health officials can’t be sure the hotel is the source until testing is complete.

The Sheraton Atlanta shut down voluntarily about two weeks ago after three guests tested positive for the disease. The hotel will remain close until August 11, depending on test results.

Legionnaire’s disease is a type of pneumonia caused by inhaling the water-borne bacteria Legionella. Symptoms include fever, fatigue, headache, and coughing.

The investigation is ongoing. No deaths have been reported.

———————————————————————————————————-

Atlanta, GA (WJBF) – The Sheraton Hotel in Atlanta has released a statement addressing the investigation of Legionnaires’ disease.

If you were a guest in the Sheraton Hotel from 6/12/2019 to 7/15/2019, you may have been exposed to Legionaries’ disease. The FCBOH received notice that people who stayed at the hotel were recently diagnosed with the condition.

The FCBOH and the DPH are conducting an assessment of the hotel. They will test water at the hotel to determine whether or not the bacteria is connected to the hotel.

If you become sick within 14 days of your stay at the Sheraton, please seek medical attention. If you have symptoms of Legionnaires’ please notify your health care provider of the statement released by Sheraton.

Guests that stayed in the hotel during this time frame are asked to complete an online survey. http://sendss.state.ga.us/survey/form/11178

For more information, please contact the Sheraton Atlanta at 404-659-6500.

Copyright 2019 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.